Molecular identification of tigecycline- and colistinresistant carbapenemase-producing Acinetobacter baumannii from a Greek hospital from 2011 to 2013

Journal of Medical Microbiology

Volumn 64, Issue 9, 2015, Pages 993-997

  Mavroidi, Angeliki ^a   Likousi, Sofia ^a   Palla, Eleftheria ^a   Katsiari, Maria ^a   Roussou, Zoi ^a   Maguina, Asimina ^a   Platsouka, Evangelia D ^a  

^a IASO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; COLISTIN; TIGECYCLINE; BACTERIAL PROTEIN; BETA LACTAMASE; MINOCYCLINE;

ACINETOBACTER BAUMANNII; ADEB GENE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLA OXA 23 GENE; BLOODSTREAM INFECTION; GREECE; INCIDENCE; INFECTION CONTROL; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; ACINETOBACTER INFECTIONS; ANALOGS AND DERIVATIVES; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MICROBIOLOGY; MULTIDRUG RESISTANCE; TIME;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTERIAL PROTEINS; BETA-LACTAMASES; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GREECE; HUMANS; MINOCYCLINE; TIME FACTORS;

EID: 84941561450     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.000127     Document Type: Article

References (20)

1. Bartha, N. A., Sóki, J., Urbán, E. & Nagy, E. (2011). Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations. Int J Antimicrob Agents 38, 522–525.
2. Bassetti, M., Righi, E., Esposito, S., Petrosillo, N. & Nicolini, L. (2008). Drug treatment for multidrug-resistant Acinetobacter baumannii infections. Future Microbiol 3, 649–660.
3. Beceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G. & other authors (2011). Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB twocomponent regulatory system. Antimicrob Agents Chemother 55, 3370–3379.
4. CLSI (2013). Performance Standards for Antimicrobial Susceptibility Testing, 23rd Informational Supplement M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute.
5. Deng, M., Zhu, M.-H., Li, J.-J., Bi, S., Sheng, Z.-K., Hu, F.-S., Zhang, J.- J., Chen, W., Xue, X.-W. & other authors (2014). Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital. Antimicrob Agents Chemother 58, 297–303.
6. Hou, P. F., Chen, X. Y., Yan, G. F., Wang, Y. P. & Ying, C. M. (2012). Study of the correlation of imipenem resistance with efflux pumps AdeABC, AdeIJK, AdeDE and AbeM in clinical isolates of Acinetobacter baumannii. Chemotherapy 58, 152–158.
7. Karaiskos, I. & Giamarellou, H. (2014). Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches. Expert Opin Pharmacother 15, 1351–1370.
8. Liakopoulos, A., Miriagou, V., Katsifas, E. A., Karagouni, A. D., Daikos, G. L., Tzouvelekis, L. S. & Petinaki, E. (2012). Identification of OXA-23-producing Acinetobacter baumannii in Greece, 2010 to 2011. Euro Surveill 17, 20117.
9. Maragakis, L. L. & Perl, T. M. (2008). Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46, 1254–1263.
10. Mendes, R. E., Farrell, D. J., Sader, H. S. & Jones, R. N. (2010). Comprehensive assessment of tigecycline activity tested against a worldwide collection of Acinetobacter spp. (2005–2009). Diagn Microbiol Infect Dis 68, 307–311.
11. Miyakis, S., Pefanis, A. & Tsakris, A. (2011). The challenges of antimicrobial drug resistance in Greece. Clin Infect Dis 53, 177–184.
12. Montefour, K., Frieden, J., Hurst, S., Helmich, C., Headley, D., Martin, M. & Boyle, D. A. (2008). Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care. Crit Care Nurse 28, 15–25, quiz 26.
13. Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N. & Bonomo, R. A. (2007). Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51, 3471–3484.
14. Poulakou, G., Kontopidou, F. V., Paramythiotou, E., Kompoti, M., Katsiari, M., Mainas, E., Nicolaou, C., Yphantis, D., Antoniadou, A. & other authors (2009). Tigecycline in the treatment of infections from multi-drug resistant Gram-negative pathogens. J Infect 58, 273–284.
15. Reis, A. O., Luz, D. A., Tognim, M. C., Sader, H. S. & Gales, A. C. (2003). Polymyxin-resistant Acinetobacter spp. isolates: what is next? Emerg Infect Dis 9, 1025–1027.
16. Samonis, G., Matthaiou, D. K., Kofteridis, D., Maraki, S. & Falagas, M. E. (2010). In vitro susceptibility to various antibiotics of colistinresistant Gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece. Clin Infect Dis 50, 1689–1691.
17. Tamura, K., Dudley, J., Nei, M. & Kumar, S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24, 1596–1599.
18. Turton, J. F., Gabriel, S. N., Valderrey, C., Kaufmann, M. E. & Pitt, T. L. (2007). Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin Microbiol Infect 13, 807–815.
19. Woodford, N., Ellington, M. J., Coelho, J. M., Turton, J. F., Ward, M. E., Brown, S., Amyes, S. G. & Livermore, D. M. (2006). Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents 27, 351–353.
20. Zarrilli, R., Pournaras, S., Giannouli, M. & Tsakris, A. (2013). Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Agents 41, 11–19.